Cellnovo Group S.A. | |
Stock Exchange | Euronext Paris |
EPS |
EUR0.98 |
Market Cap |
EUR2.26 M |
Shares Outstanding |
17.64 M |
Public Float |
11.25 M |
Address |
13, rue de Londres Paris Ile-de-France 75009 France |
Employees | - |
Website | http://www.cellnovo.com |
Updated | 07/08/2019 |
Cellnovo Group SA is a medical technology company, which specializes in diabetes. The company develops and markets the first mobile, connected, all-in-one diabetes management system that helps make life easier for patients. Its products portfolio includes system, switch, pump therapy, and patient stories. |